| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway | Wu T.-S.; CHING-TING TAN ; Chang C.-C.; Lin B.-R.; Lai W.-T.; Chen S.-T.; Yen-Ping Kuo M.; Rau C.-L.; Jaw F.-S.; Chang H.-H. | Oncogene | 9 | 9 | |
| 2015 | B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway | Wu T.-S.; Tan C.-T.; Chang C.-C.; BEEN-REN LIN ; Lai W.-T.; Chen S.-T.; Yen-Ping Kuo M.; Rau C.-L.; Jaw F.-S.; Chang H.-H. | Oncogene | 9 | 9 | |
| 2015 | B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway | Wu T.-S.; Tan C.-T.; Chang C.-C.; Lin B.-R.; Lai W.-T.; Chen S.-T.; YEN-PING KUO ; Rau C.-L.; Jaw F.-S.; Chang H.-H. | Oncogene | 9 | ||
| 1990 | Bone changes in hyperthyroidism - A preliminary study | Chen S.-T.; Huang M.-J.; Juang J.-H.; Lin J.-D.; Huang B.-Y.; Huang H.-S.; KAI-YUAN TZEN | Chang Gung Medical Journal | 0 | ||
| 2005 | Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: A multigenic study on cancer susceptibility | Cheng T.-C.; Chen S.-T.; CHIUN-SHENG HUANG ; Fu Y.-P.; Yu J.-C.; Cheng C.-W.; Wu P.-E.; Shen C.-Y. | International Journal of Cancer | 116 | 107 | |
| 2006 | Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: A multigenic study on cancer susceptibility | Yu J.-C.; Hsu H.-M.; Chen S.-T.; Hsu G.-C.; CHIUN-SHENG HUANG ; Hou M.-F.; Fu Y.-P.; Cheng T.-C.; Wu P.-E.; Shen C.-Y. | Journal of Biomedical Science | 26 | 23 | |
| 2022 | C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma | Lin N.-Y.; Chen S.-T.; Chang H.-L.; Lu M.-Y.; Yang Y.-L.; Chou S.-W.; Lin D.-T.; Lin K.-H.; Jou S.-T.; Hsu W.-M.; Huang M.-C.; HSIU-HAO CHANG | Oncogenesis | 0 | ||
| 2022 | C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma | Lin N.-Y.; Chen S.-T.; Chang H.-L.; Lu M.-Y.; Yang Y.-L.; Chou S.-W.; Lin D.-T.; Lin K.-H.; SHIANN-TANG JOU ; Hsu W.-M.; Huang M.-C.; Chang H.-H. | Oncogenesis | 0 | ||
| 2021 | C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv | Kuo T.-C.; Wu M.-H.; Yang S.-H.; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; YU-WEN TIEN ; Huang M.-C. | Oncogene | 9 | 8 | |
| 2021 | C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv | Kuo T.-C.; MING-HSUN WU ; Yang S.-H.; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. | Oncogene | 8 | ||
| 2021 | C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin �\v | Kuo T.-C.; Wu M.-H.; SHIH-HUNG YANG ; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. | Oncogene | 9 | 8 | |
| 2020 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer | Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; CHIA-LANG HSU ; Juan H.-F.; Lee P.-H.; Huang M.-C. | Oncogene | 12 | 10 | |
| 2020 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer | Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; PO-HUANG LEE ; Huang M.-C. | Oncogene | 12 | 10 | |
| 2020 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer | Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; JI-SHIANG HUNG ; Hsu C.-L.; Juan H.-F.; Lee P.-H.; Huang M.-C. | Oncogene | 4 | 10 | |
| 2020 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer | Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; Lee P.-H.; MIN-CHUAN HUANG | Oncogene | 3 | 10 | |
| 2020 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer | PO-CHU LEE ; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; Lee P.-H.; Huang M.-C. | Oncogene | 10 | ||
| 2020 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer | Lee P.-C.; Chen S.-T.; TING-CHUN KUO ; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; Lee P.-H.; Huang M.-C. | Oncogene | 10 | ||
| 2018 | C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer | Lin M.-C.; Chien P.-H.; Wu H.-Y.; Chen S.-T.; Juan H.-F. ; Lou P.-J.; Huang M.-C. | Oncogene | 5 | 27 | |
| 2018 | C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer | MEI-CHUN LIN ; Chien P.-H.; Wu H.-Y.; Chen S.-T.; Juan H.-F.; Lou P.-J.; Huang M.-C. | Oncogene | 26 | 27 | |
| 2018 | C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer | Lin M.-C.; Chien P.-H.; Wu H.-Y.; Chen S.-T.; Juan H.-F.; Lou P.-J.; MIN-CHUAN HUANG | Oncogene | 5 | 27 |
